Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis

Pediatric and Developmental Pathology

Volumn 13, Issue 2, 2010, Pages 101-106

  Galluzzo, Maria Laura ^a   Braier, Jorge ^a   Rosenzweig, Sergio D ^a   Garcia De Dávila, Maria T ^a   Rosso, Diego ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Cytopenias; Emperipolesis; Hemophagocytosis; Histiocytosis; Langerhans; Myelofibrosis

Indexed keywords

ANTIGEN; CD 1 ALPHA ANTIGEN; CD68 ANTIGEN; EOSIN; HEMATOXYLIN; RETICULIN; SCHIFF BASE; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW BIOPSY; CHILD; CLINICAL ARTICLE; DYSPLASIA; ERYTHROPHAGOCYTOSIS; FEMALE; GIEMSA STAIN; HEMATOLOGIC DISEASE; HISTIOCYTE; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEGAKARYOCYTE; MONOCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL;

BONE MARROW; BONE MARROW EXAMINATION; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 77951941579     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/09-05-0651-OA.1     Document Type: Article

References (24)

1. Bechan GI, Meeker AK, De Marzo AM, et al. Telomere length shortening in Langerhans cell histiocytosis. Br J Haematol 2008;140:420-428.
2. Broadbent V, Gadner H, Komp DM, Ladisch S. Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Med Pediatr Oncol 1989;17:492-495.
3. Lahey ME. Histiocytosis X: an analysis of prognostic factors. J Pediatr 1975;87:184-189.
4. Nezelof C, Frileux-Herbet F, Cronier-Sachot J. Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979;44:1824-1838. (Pubitemid 10141962)
5. McClain K, Ramsay NKC, Robison L, Sundberg RD, Nesbit M Jr. Bone marrow involvement in histiocytosis X. Med Pediatr Oncol 1983;11:167-171.
6. Minkov M, Pötschger U, Grois N, Gadner H, Dworzak MN. Bone marrow assessment in Langerhans cell histiocytosis. Pediatr Blood Cancer 2007;49:694-698. (Pubitemid 350194437)
7. Surico G, Muggeo P, Rigillo N, Gadner H. Concurrent Langerhans cell histiocytosis and myelodysplasia in children. Med Pediatr Oncol 2000;35:421-425.
8. Piguet C, Ketterer S, Gilbert B, De Lumley L. Langerhans' histiocytosis and medullar fibrosis [in French]. Arch Pédiatr 1998;5:1045-1048.
9. Braier J, Chantada G, Rosso D, et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999;16:377-385. (Pubitemid 29409161)
10. Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol 2002;5:130-140. (Pubitemid 34475445)
11. Gadner H, Grois N, Pötschger U, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2008;111:2556-2562.
12. Friebert SE, Shepardson LB, Shurin SB, Rosenthal GE, Rosenthal NS. Pediatric bone marrow cellularity: are we expecting too much? J Pediatr Hematol Oncol 1998;20:439-443.
13. Bauermeister DE. Quantification of bone marrow reticulin: abnormal range. Am J Clin Pathol 1971;56:24-31.
14. Humble JG, Jayne WHW, Pulvertaft RJ. Biological interaction between lymphocytes and other cells. Br J Haematol 1956;2:283-294.
15. Cashell AW, Buss DH. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. Ann Haematol 1992;64:273-276.
16. Pinckney L, Parker B. Myelosclerosis and myelofibrosis in treated histiocytosis-X. Am J Roentgenol 1977;129:521-523.
17. Sartori DJ, Resnick D. Myelofibrosis arising in treated histiocytosis X. Eur J Pediatr 1985;144:200-202.
18. Thiele J, Steinberg T, Hoeppner B, et al. Histo and immunomorphometry of megakaryopoieses in chronic myeloid leukaemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/sclerosis. Anal Cell Pathol 1990;2:215-227. (Pubitemid 20185069)
19. Thiele J, Kuemmel T, Sander C, Fischer R. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosisosteomyelosclerosis (agnogenic myeloid metaplasia). I Abnormalities of megakaryopoiesis and thrombocytes. J Submicrosc Cytol Pathol 1991;23:93-107.
20. Bobik R, Podolak-Dawidziak M, Kiełbiński M, Jeleń M, Wróbel T. Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders. Acta Haematol Pol 1995;26:179-183.
21. Schmitt A, Jouault H, Guichard J, Wendling F, Drouin A, Cramer EM. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 2000;96:1342-1347. (Pubitemid 30658462)
22. Schmitt A, Drouin A, Massé JM, Guichard J, Shagraoui H, Cramer EM. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis. Leuk Lymphoma 2002;43:719-724. (Pubitemid 34428658)
23. Centurione L, Di Baldassarre A, Zingariello M, et al. Increased and pathologic emperipolesis of neutrophils with megakaryocytes associated with marrow fibrosis in GATA (low) mice. Blood 2004;104:3573-3580
24. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 2005;23:8520-8530.